reference/1584514

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1584514

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	174
issn	1875-9114 0277-0008
issueIdentifier	2
pageRange	166-174
publicationName	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
startingPage	166
bibliographicCitation	Pathak DS, Davis EA, Stanford RH. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population. Pharmacotherapy. 2002 Feb;22(2):166–74. doi: 10.1592/phco.22.3.166.33548. PMID: 11837555.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbe342a2554126cdb059445c01421b25 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d4259ec565d1e299fcc1d16eb73116f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4fc89d8239fc1fed414ea4272469b7d
date	200202
identifier	https://doi.org/10.1592/phco.22.3.166.33548 https://pubmed.ncbi.nlm.nih.gov/11837555
isPartOf	https://portal.issn.org/resource/ISSN/1875-9114 https://portal.issn.org/resource/ISSN/0277-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6511
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Economic Impact of Asthma Therapy with Fluticasone Propionate, Montelukast, or Zafirlukast in a Managed Care Population
discusses	http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0020772 http://id.nlm.nih.gov/mesh/M0028296 http://id.nlm.nih.gov/mesh/M0018350 http://id.nlm.nih.gov/mesh/M0247416 http://id.nlm.nih.gov/mesh/M0005491 http://id.nlm.nih.gov/mesh/M0173494 http://id.nlm.nih.gov/mesh/M000602354 http://id.nlm.nih.gov/mesh/M0461443 http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M0001108 http://id.nlm.nih.gov/mesh/M0000125 http://id.nlm.nih.gov/mesh/M0021712 http://id.nlm.nih.gov/mesh/M0001333
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000085Q000191 http://id.nlm.nih.gov/mesh/D011804Q000191 http://id.nlm.nih.gov/mesh/D000730Q000191 http://id.nlm.nih.gov/mesh/D008329Q000191 http://id.nlm.nih.gov/mesh/D001249Q000191 http://id.nlm.nih.gov/mesh/D014105Q000191
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000730Q000008 http://id.nlm.nih.gov/mesh/D000085Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D048448 http://id.nlm.nih.gov/mesh/D011804Q000008 http://id.nlm.nih.gov/mesh/D000085Q000627 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D018927Q000191 http://id.nlm.nih.gov/mesh/D018927Q000008 http://id.nlm.nih.gov/mesh/D014105Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D003521 http://id.nlm.nih.gov/mesh/D001249Q000188 http://id.nlm.nih.gov/mesh/D000730Q000627 http://id.nlm.nih.gov/mesh/D001249Q000453 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D014105Q000627 http://id.nlm.nih.gov/mesh/D007211 http://id.nlm.nih.gov/mesh/D013449 http://id.nlm.nih.gov/mesh/D018927Q000627 http://id.nlm.nih.gov/mesh/D000893Q000627 http://id.nlm.nih.gov/mesh/D000893Q000191 http://id.nlm.nih.gov/mesh/D000893Q000008 http://id.nlm.nih.gov/mesh/D000280 http://id.nlm.nih.gov/mesh/D014481Q000453 http://id.nlm.nih.gov/mesh/D000068298 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D013440 http://id.nlm.nih.gov/mesh/D011804Q000627 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D015331
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6985 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281040 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5717 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444036

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129153627 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129347866 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129783076 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136316904 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129604518

Total number of triples: 84.